N-acetyl cysteine (NAC) is emerging as a valuable adjunctive therapy for bipolar disorder, particularly for persistent depressive symptoms. By replenishing glutathione, modulating glutamate, reducing inflammation, and supporting mitochondrial function, NAC targets key biological drivers of mood instability. This article reviews the mechanisms, clinical evidence, dosing, and safety considerations for integrating NAC into bipolar care.